Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) has announced its first buyback of A-shares, executed through centralized bidding transactions on September 17, 2026.
During this transaction, the company repurchased a total of 335,000 shares, accounting for 0.005% of its overall share capital. The shares were acquired at a maximum price of 43.58 yuan per share and a minimum price of 43.10 yuan per share.
The aggregate amount paid for this repurchase reached 14.5036 million yuan, excluding transaction fees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments